Extending Serum Half-life of Albumin by Engineering Neonatal Fc Receptor (FcRn) Binding

Crystal structure of human serum albumin at 2.5 Å resolution

Sugio, S., Kashima, A., Mochizuki, S., Noda, M., & Kobayashi, K. (1999) · Protein Engineering Design and Selection · doi:10.1093/protein/12.6.439 · Cited by 1,816

Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites

Curry, S., Mandelkow, H., Brick, P., & Franks, N. P. (1998) · Nature Structural Biology · doi:10.1038/1869 · Cited by 1,378

Quantitative analysis of protein far UV circular dichroism spectra by neural networks

Böhm, G., Muhr, R., & Jaenicke, R. (1992) · Protein Engineering Design and Selection · doi:10.1093/protein/5.3.191 · Cited by 1,114

Impact of albumin on drug delivery — New applications on the horizon

Elsadek, B., & Kratz, F. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.069 · Cited by 853

Therapeutic antibodies for autoimmunity and inflammation

Chan, A. C., & Carter, P. J. (2010) · Nature reviews. Immunology · doi:10.1038/nri2761 · Cited by 846

Enhanced antibody half-life improves in vivo activity

Zalevsky, J., Chamberlain, A. K., Horton, H. M., Karki, S., Leung, I., Sproule, T. J., Lazar, G. A., Roopenian, D. C., & Desjarlais, J. R. (2010) · Nature Biotechnology · doi:10.1038/nbt.1601 · Cited by 667

The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan

Chaudhury, C., Mehnaz, S., Robinson, J. M., Hayton, W. L., Pearl, D. K., Roopenian, D. C., & Anderson, C. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021829 · Cited by 640

Albumin as a versatile platform for drug half-life extension

Sleep, D., Cameron, J., & Evans, L. R. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.023 · Cited by 510

Crystal structural analysis of human serum albumin complexed with hemin and fatty acid

Zunszain, P. A., Ghuman, J., Komatsu, T., Tsuchida, E., & Curry, S. (2003) · BMC Structural Biology · doi:10.1186/1472-6807-3-6 · Cited by 509

Differences in promiscuity for antibody–FcRn interactions across species: implications for therapeutic antibodies

Ober, R. J., Radu, C. G., Ghetie, V. F., & Ward, E. S. (2001) · International Immunology · doi:10.1093/intimm/13.12.1551 · Cited by 502

Crystal structure of the complex of rat neonatal Fc receptor with Fc

Burmeister, W. P., Huber, A. H., & Björkman, P. J. (1994) · Nature · doi:10.1038/372379a0 · Cited by 442

Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels

Vaccaro, C., Zhou, J., Ober, R. J., & Ward, E. S. (2005) · Nature Biotechnology · doi:10.1038/nbt1143 · Cited by 407

Crystal structure of the complex of rat neonatal Fc receptor with Fc

(1995) · Trends in Genetics · doi:10.1016/0168-9525(95)90005-5 · Cited by 382

A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus.

Story, C. M., Mikulska, J., & Simister, N. E. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.6.2377 · Cited by 354

Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease

Petkova, S. B., Akilesh, S., Sproule, T. J., Christianson, G. J., Khabbaz, H. J. A., Brown, A. C., Presta, L. G., Meng, Y. G., & Roopenian, D. C. (2006) · International Immunology · doi:10.1093/intimm/dxl110 · Cited by 319

Albumin Binding to FcRn: Distinct from the FcRn−IgG Interaction

Chaudhury, C., Brooks, C. L., Carter, D. C., Robinson, J. M., & Anderson, C. L. (2006) · Biochemistry · doi:10.1021/bi052628y · Cited by 290

Engineered Human IgG Antibodies with Longer Serum Half-lives in Primates

Hinton, P. R., Johlfs, M. G., Xiong, J. M., Hanestad, K., Ong, K. C., Bullock, C., Keller, S., Tang, M. T., Tso, J. Y., Vásquez, M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300470200 · Cited by 277

Neonatal FcR Expression in Bone Marrow-Derived Cells Functions to Protect Serum IgG from Catabolism

Akilesh, S., Christianson, G. J., Roopenian, D. C., & Shaw, A. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4580 · Cited by 276

Crystallographic Analysis of Human Serum Albumin Complexed with 4Z,15E-Bilirubin-IXα

Zunszain, P. A., Ghuman, J., McDonagh, A. F., & Curry, S. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.06.016 · Cited by 267

Crystal Structure and Immunoglobulin G Binding Properties of the Human Major Histocompatibility Complex-Related Fc Receptor ,

West, A. P., & Björkman, P. J. (2000) · Biochemistry · doi:10.1021/bi000749m · Cited by 261

Structural Insights into Neonatal Fc Receptor-based Recycling Mechanisms

Oganesyan, V., Damschroder, M. M., Cook, K. E., Li, Q., Gao, C., Wu, H., & Dall'Acqua, W. F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.537563 · Cited by 259

Increasing the serum persistence of an IgG fragment by random mutagenesis

Ghetie, V. F., Popov, S. G., Borvak, J., Radu, C. G., Matesoi, D., Medesan, C., Ober, R. J., & Ward, E. S. (1997) · Nature Biotechnology · doi:10.1038/nbt0797-637 · Cited by 253

Conditional deletion of the MHC class I-related receptor FcRn reveals the sites of IgG homeostasis in mice

Montoyo, H. P., Vaccaro, C., Hafner, M., Ober, R. J., Mueller, W., & Ward, E. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810796106 · Cited by 211

Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor

Andersen, J. T., Dalhus, B., Cameron, J., Daba, M. B., Plumridge, A., Evans, L. R., Brennan, S. O., Gunnarsen, K. S., Bjørås, M., Sleep, D., et al. (2012) · Nature Communications · doi:10.1038/ncomms1607 · Cited by 206

Cross-species Binding Analyses of Mouse and Human Neonatal Fc Receptor Show Dramatic Differences in Immunoglobulin G and Albumin Binding

Andersen, J. T., Daba, M. B., Berntzen, G., Michaelsen, T. E., & Sandlie, I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081828 · Cited by 200

Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients

Santagostino, E., Négrier, C., Klamroth, R., Tiede, A., Pabinger-Fasching, I., Voigt, C., Jacobs, I. C., & Morfini, M. (2012) · Blood · doi:10.1182/blood-2012-05-429688 · Cited by 177

The Versatile MHC Class I-related FcRn Protects IgG and Albumin from Degradation: Implications for Development of New Diagnostics and Therapeutics

Andersen, J. T., & Sandlie, I. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.318 · Cited by 124

The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH‐dependent binding to albumin

Andersen, J. T., Qian, J. D., & Sandlie, I. (2006) · European Journal of Immunology · doi:10.1002/eji.200636556 · Cited by 123

Crystal Structure of an HSA/FcRn Complex Reveals Recycling by Competitive Mimicry of HSA Ligands at a pH-Dependent Hydrophobic Interface

Schmidt, M. M., Townson, S. A., Andreucci, A., King, B. M., Schirmer, E. B., Murillo, A., Dombrowski, C., Tisdale, A. W., Lowden, P., Masci, A., et al. (2013) · Structure · doi:10.1016/j.str.2013.08.022 · Cited by 121

An FcRn-Dependent Role for Anti-flagellin Immunoglobulin G in Pathogenesis of Colitis in Mice

Kobayashi, K., Qiao, S., Yoshida, M., Baker, K., Lencer, W. I., & Blumberg, R. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.059 · Cited by 88

Single-chain Variable Fragment Albumin Fusions Bind the Neonatal Fc Receptor (FcRn) in a Species-dependent Manner

Andersen, J. T., Cameron, J., Plumridge, A., Evans, L. R., Sleep, D., & Sandlie, I. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.463000 · Cited by 68

Cloning and Expression of the Neonatal Rat Intestinal Fc Receptor, a Major Histocompatibility Complex Class I Antigen HomologPreprint

Simister, N. E., & Mostov, K. E. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.068 · Cited by 64

The production, characterisation and enhanced pharmacokinetics of scFv–albumin fusions expressed in Saccharomyces cerevisiae

Evans, L. R., Hughes, M., Waters, J., Cameron, J., Dodsworth, N., Tooth, D., Greenfield, A., & Sleep, D. (2010) · Protein Expression and Purification · doi:10.1016/j.pep.2010.05.009 · Cited by 40

FcRn binding properties of an abnormal truncated analbuminemic albumin variant

Andersen, J. T., Daba, M. B., & Sandlie, I. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.12.001 · Cited by 35

Ligand binding and antigenic properties of a human neonatal Fc receptor with mutation of two unpaired cysteine residues

Andersen, J. T., Justesen, S. F. L., Fleckenstein, B. T., Michaelsen, T. E., Berntzen, G., Kenanova, V. E., Daba, M. B., Lauvrak, V., Buus, S., & Sandlie, I. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06551.x · Cited by 31

A homozygote for a serum albumin variant of the fast type

Vanzetti, G., Porta, F., Prencipe, L., Scherini, A., & Fraccaro, M. (1979) · Human Genetics · doi:10.1007/bf00278896 · Cited by 11

Untitled work

(1999) · doi:10.1002/(sici)1521-4141(199909)29:09

Hypoalbuminemia: Pathogenesis and Clinical Significance

Soeters, P. B., Wolfe, R. R., & Shenkin, A. (2019) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1451 · Cited by 1,448

Albumin-based drug delivery: harnessing nature to cure disease

Larsen, M. T., Kuhlmann, M., Hvam, M. L., & Howard, K. A. (2016) · Molecular and Cellular Therapies · doi:10.1186/s40591-016-0048-8 · Cited by 704

Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters

Strohl, W. R. (2015) · BioDrugs · doi:10.1007/s40259-015-0133-6 · Cited by 479

Albumin and its application in drug delivery

Sleep, D. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.993313 · Cited by 470

The Neonatal Fc Receptor (FcRn): A Misnomer?

Pyzik, M., Sand, K. M. K., Hubbard, J. J., Andersen, J. T., Sandlie, I., & Blumberg, R. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01540 · Cited by 450

Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRnin vitroandin vivo

Mester, S., Evers, M., Meyer, S., Nilsen, J., Greiff, V., Sandlie, I., Leusen, J. H. W., & Andersen, J. T. (2021) · mAbs · doi:10.1080/19420862.2021.1893888 · Cited by 54

Serum albumin and its interaction with the neonatal Fc receptor (FcRn) : characterization of the albumin/FcRn-binding mechanism

Färber-Schwarz, A. (2013) · OPUS Publication Server of the University of Stuttgart (University of Stuttgart) · doi:10.18419/opus-2165

The Influence of FcRn on Albumin-Fused and Targeted Drugs

Nilsen, J., Sand, K. M. K., Bern, M., Lei, P., Sandlie, I., & Andersen, J. T. (2016) · Springer eBooks · doi:10.1007/978-981-10-2116-9_10 · Cited by 1

Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain

Andersen, J. T., Pehrson, R., Максимилианович, Т. В., Daba, M. B., Abrahmsén, L., & Ekblad, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.164848 · Cited by 178

Enhanced plasma half-life and efficacy of engineered human albumin-fused GLP-1 despite enzymatic cleavage of its C-terminal end

Nilsen, J., Aaen, K. H., Benjakul, S., Ruso‐Julve, F., Greiner, T. U., Bejan, D., Stensland, M., Singh, S. K., Schlothauer, T., Sandlie, I., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08249-8 · Cited by 21